Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Cervical Cancer

  Free Subscription


Articles published in Gynecol Oncol

Retrieve available abstracts of 191 articles:
HTML format
Text format



Single Articles


    July 2018
  1. XUE R, Cai X, Xu H, Wu S, et al
    The efficacy of concurrent weekly carboplatin with radiotherapy in the treatment of cervical cancer: A meta-analysis.
    Gynecol Oncol. 2018 Jul 8. pii: S0090-8258(18)31018.
    PubMed     Text format     Abstract available


    June 2018
  2. ROGERI CD, Silveira HCS, Causin RL, Villa LL, et al
    Methylation of the hsa-miR-124, SOX1, TERT, and LMX1A genes as biomarkers for precursor lesions in cervical cancer.
    Gynecol Oncol. 2018 Jun 27. pii: S0090-8258(18)30990.
    PubMed     Text format     Abstract available


  3. LEATH CA 3RD, Monk BJ
    Twenty-first century cervical cancer management: A historical perspective of the gynecologic oncology group/NRG oncology over the past twenty years.
    Gynecol Oncol. 2018 Jun 26. pii: S0090-8258(18)31005.
    PubMed     Text format     Abstract available


  4. RAUH LA, Saks EJ, Nakad-Rodriguez D, Showalter TN, et al
    Cervical cancer care in rural Virginia: The impact of distance from an academic medical center on outcomes & the role of non-specialized radiation centers.
    Gynecol Oncol. 2018 Jun 20. pii: S0090-8258(18)31001.
    PubMed     Text format     Abstract available


    May 2018
  5. YAGUR Y, Weitzner O, Gemer O, Lavie O, et al
    Postoperative radiation rates in stage IIA1 cervical cancer: Is surgical treatment justified? An Israeli Gynecologic Oncology Group Study.
    Gynecol Oncol. 2018 May 25. pii: S0090-8258(18)30903.
    PubMed     Text format     Abstract available


  6. SALVO G, Frumovitz M, Pareja R, Lee J, et al
    Simple trachelectomy with pelvic lymphadenectomy as a viable treatment option in pregnant patients with stage IB1 (>/=2cm) cervical cancer: Bridging the gap to fetal viability.
    Gynecol Oncol. 2018 May 24. pii: S0090-8258(18)30908.
    PubMed     Text format     Abstract available


  7. PHILP L, Jembere N, Wang L, Gao J, et al
    Pap tests in the diagnosis of cervical cancer: Help or hinder?
    Gynecol Oncol. 2018 May 15. pii: S0090-8258(18)30906.
    PubMed     Text format     Abstract available


  8. TSENG JH, Aloisi A, Sonoda Y, Gardner GJ, et al
    Less versus more radical surgery in stage IB1 cervical cancer: A population-based study of long-term survival.
    Gynecol Oncol. 2018 May 15. pii: S0090-8258(18)30849.
    PubMed     Text format     Abstract available


  9. DAVIS M, Strickland K, Easter SR, Worley M Jr, et al
    The impact of health insurance status on the stage of cervical cancer diagnosis at a tertiary care center in Massachusetts.
    Gynecol Oncol. 2018 May 8. pii: S0090-8258(18)30887.
    PubMed     Text format     Abstract available


  10. TRIMBLE CL
    Towards identifying new therapeutic targets in cancers attributable to HPV.
    Gynecol Oncol. 2018;149:225-226.
    PubMed     Text format    


    April 2018
  11. MAYADEV J, Klapheke A, Yashar C, Hsu IC, et al
    Underutilization of brachytherapy and disparities in survival for patients with cervical cancer in California.
    Gynecol Oncol. 2018 Apr 27. pii: S0090-8258(18)30841.
    PubMed     Text format     Abstract available


  12. EL-ZEIN M, Bouten S, Louvanto K, Gilbert L, et al
    Validation of a new HPV self-sampling device for cervical cancer screening: The Cervical and Self-Sample In Screening (CASSIS) study.
    Gynecol Oncol. 2018 Apr 17. pii: S0090-8258(18)30274.
    PubMed     Text format     Abstract available


  13. MATODA M, Takeshima N, Michimae H, Iwata T, et al
    Postoperative chemotherapy for node-positive cervical cancer: Results of a multicenter phase II trial (JGOG1067).
    Gynecol Oncol. 2018 Apr 13. pii: S0090-8258(18)30286.
    PubMed     Text format     Abstract available


  14. DOCKERY LE, Motwani A, Ding K, Doescher M, et al
    Improving cancer care for American Indians with cervical cancer in the Indian Health Service (IHS) system - Navigation may not be enough.
    Gynecol Oncol. 2018;149:89-92.
    PubMed     Text format     Abstract available


  15. HAGOPIAN GS, Lieber M, Dottino PR, Margaret Kemeny M, et al
    The impact of nativity on cervical cancer survival in the public hospital system of Queens, New York.
    Gynecol Oncol. 2018;149:63-69.
    PubMed     Text format     Abstract available


  16. RAMEY SJ, Asher D, Kwon D, Ahmed AA, et al
    Delays in definitive cervical cancer treatment: An analysis of disparities and overall survival impact.
    Gynecol Oncol. 2018;149:53-62.
    PubMed     Text format     Abstract available


  17. STAPLES JN, Wong MS, Rimel BJ
    An educational intervention to improve human papilloma virus (HPV) and cervical cancer knowledge among African American college students.
    Gynecol Oncol. 2018;149:101-105.
    PubMed     Text format     Abstract available


  18. MAO X, Qin X, Li L, Zhou J, et al
    A 15-long non-coding RNA signature to improve prognosis prediction of cervical squamous cell carcinoma.
    Gynecol Oncol. 2018;149:181-187.
    PubMed     Text format     Abstract available


    March 2018
  19. CHEN L, Luan S, Xia B, Liu Y, et al
    Integrated analysis of HPV-mediated immune alterations in cervical cancer.
    Gynecol Oncol. 2018 Mar 20. pii: S0090-8258(18)30070.
    PubMed     Text format     Abstract available


  20. KANAO H, Aoki Y, Hisa T, Takeshima N, et al
    Laparoscopic laterally extended endopelvic resection (LEER) for cervical carcinoma recurring at the pelvic sidewall after concurrent chemoradiotherapy: Our experience in three cases.
    Gynecol Oncol. 2018 Mar 3. pii: S0090-8258(18)30112.
    PubMed     Text format     Abstract available


  21. HARKENRIDER MM, Altoos B, Small W Jr.
    Prognostic significance of residual lymph node status after definitive chemoradiotherapy in patients with node-positive cervical cancer.
    Gynecol Oncol. 2018;148:437-438.
    PubMed     Text format    


  22. MINION LE, Tewari KS
    Cervical cancer - State of the science: From angiogenesis blockade to checkpoint inhibition.
    Gynecol Oncol. 2018;148:609-621.
    PubMed     Text format     Abstract available


    February 2018
  23. PAREJA R, Echeverri L, Rendon G, Munsell M, et al
    Radical parametrectomy after 'cut-through' hysterectomy in low-risk early-stage cervical cancer: Time to consider this procedure obsolete.
    Gynecol Oncol. 2018 Feb 23. pii: S0090-8258(18)30134.
    PubMed     Text format     Abstract available


  24. THARAVICHITKUL E, Chakrabandhu S, Klunklin P, Onchan W, et al
    Intermediate-term results of trans-abdominal ultrasound (TAUS)-guided brachytherapy in cervical cancer.
    Gynecol Oncol. 2018 Feb 2. pii: S0090-8258(18)30047.
    PubMed     Text format     Abstract available


  25. KANG WD, Ju UC, Kim SM
    Is human papillomavirus genotype important in predicting disease progression in women with biopsy-proven negative or CIN1 of atypical squamous cell of undetermined significance (ASC-US) cytology?
    Gynecol Oncol. 2018;148:305-310.
    PubMed     Text format     Abstract available


    January 2018
  26. DEWDNEY SB, Dancisak AC, Lachance JA, Grendys EC Jr, et al
    Society of Gynecologic Oncology Clinical Outcomes Registry: From small beginnings come great things.
    Gynecol Oncol. 2018 Jan 30. pii: S0090-8258(18)30060.
    PubMed     Text format     Abstract available


  27. ZHANG HR, Lai SY, Huang LJ, Zhang ZF, et al
    Myosin 1b promotes cell proliferation, migration, and invasion in cervical cancer.
    Gynecol Oncol. 2018 Jan 27. pii: S0090-8258(18)30065.
    PubMed     Text format     Abstract available


  28. DOSTALEK L, Zikan M, Fischerova D, Kocian R, et al
    SLN biopsy in cervical cancer patients with tumors larger than 2cm and 4cm.
    Gynecol Oncol. 2018 Jan 21. pii: S0090-8258(18)30001.
    PubMed     Text format     Abstract available


  29. PARK SH, Cheon H, Chong GO, Jeong SY, et al
    Prognostic significance of residual lymph node status after definitive chemoradiotherapy in patients with node-positive cervical cancer.
    Gynecol Oncol. 2018 Jan 9. pii: S0090-8258(18)30037.
    PubMed     Text format     Abstract available


  30. BACORRO W, Dumas I, Escande A, Gouy S, et al
    Dose-volume effects in pathologic lymph nodes in locally advanced cervical cancer.
    Gynecol Oncol. 2018 Jan 8. pii: S0090-8258(17)31621.
    PubMed     Text format     Abstract available


  31. DONG L, Wang MZ, Zhao XL, Feng RM, et al
    Human papillomavirus viral load as a useful triage tool for non-16/18 high-risk human papillomavirus positive women: A prospective screening cohort study.
    Gynecol Oncol. 2018;148:103-110.
    PubMed     Text format     Abstract available


  32. GOROSTIDI M, Villalain C, Ruiz R, Jaunarena I, et al
    Technique for precaval and laterocaval nodes excision at extraperitoneal paraaortic lymphadenectomy.
    Gynecol Oncol. 2018;148:233-234.
    PubMed     Text format     Abstract available


    December 2017
  33. XIANG L, Jiang W, Ye S, He T, et al
    ERBB2 mutation: A promising target in non-squamous cervical cancer.
    Gynecol Oncol. 2017 Dec 23. pii: S0090-8258(17)31614.
    PubMed     Text format     Abstract available


  34. MONTEALEGRE JR, Peckham-Gregory EC, Marquez-Do D, Dillon L, et al
    Racial/ethnic differences in HPV 16/18 genotypes and integration status among women with a history of cytological abnormalities.
    Gynecol Oncol. 2017 Dec 21. pii: S0090-8258(17)31597.
    PubMed     Text format     Abstract available


  35. LEE J, Lin JB, Chang CL, Sun FJ, et al
    Impact of para-aortic recurrence risk-guided intensity-modulated radiotherapy in locally advanced cervical cancer with positive pelvic lymph nodes.
    Gynecol Oncol. 2017 Dec 18. pii: S0090-8258(17)31550.
    PubMed     Text format     Abstract available


  36. CASTLE PE, Pierz A, Stoler MH
    A systematic review and meta-analysis on the attribution of human papillomavirus (HPV) in neuroendocrine cancers of the cervix.
    Gynecol Oncol. 2017 Dec 13. pii: S0090-8258(17)31548.
    PubMed     Text format     Abstract available


  37. DILLEY S, Miller K, Huh W
    HPV vaccination.
    Gynecol Oncol. 2017 Dec 12. pii: S0090-8258(17)31547.
    PubMed     Text format    


  38. BIZZARRI N, Ghirardi V, Kucukmetin A
    Indocyanine green-assisted parametrial dissection during type C1 radical hysterectomy after sentinel lymph node biopsy in early stage cervical cancer.
    Gynecol Oncol. 2017 Dec 6. pii: S0090-8258(17)31496.
    PubMed     Text format     Abstract available


  39. PEI X, Xiang L, Ye S, He T, et al
    Cycles of cisplatin and etoposide affect treatment outcomes in patients with FIGO stage I-II small cell neuroendocrine carcinoma of the cervix.
    Gynecol Oncol. 2017;147:589-596.
    PubMed     Text format     Abstract available


  40. MAHANTSHETTY U, Teni T, Naga P, Hotwani C, et al
    Impact of HPV 16/18 infection on clinical outcomes in locally advanced cervical cancers treated with radical radio (chemo) therapy - A prospective observational study.
    Gynecol Oncol. 2017 Dec 1. pii: S0090-8258(17)31544.
    PubMed     Text format     Abstract available


    November 2017
  41. CHOLLI P, Bradford L, Manga S, Nulah K, et al
    Screening for cervical cancer among HIV-positive and HIV-negative women in Cameroon using simultaneous co-testing with careHPV DNA testing and visual inspection enhanced by digital cervicography: Findings of initial screening and one-year follow-up.
    Gynecol Oncol. 2017 Nov 15. pii: S0090-8258(17)31497.
    PubMed     Text format     Abstract available


  42. CHONG GO, Lee YH, Han HS, Lee HJ, et al
    Prognostic value of pre-treatment human papilloma virus DNA status in cervical cancer.
    Gynecol Oncol. 2017 Nov 15. pii: S0090-8258(17)31498.
    PubMed     Text format     Abstract available


  43. LIE AK, Trope A, Skare GB, Bjorge T, et al
    HPV genotype profile in a Norwegian cohort with ASC-US and LSIL cytology with three year cumulative risk of high grade cervical neoplasia.
    Gynecol Oncol. 2017 Nov 11. pii: S0090-8258(17)31453.
    PubMed     Text format     Abstract available


  44. SPAANS VM, Nyoman Bayu Mahendra I, Purwoto G, Trietsch MD, et al
    The landscape of somatic mutations in Indonesian cervical cancer is predominated by the PI3K pathway.
    Gynecol Oncol. 2017 Nov 4. pii: S0090-8258(17)31369.
    PubMed     Text format     Abstract available


  45. ISHIKAWA M, Kasamatsu T, Tsuda H, Fukunaga M, et al
    Prognostic factors and optimal therapy for stages I-II neuroendocrine carcinomas of the uterine cervix: A multi-center retrospective study.
    Gynecol Oncol. 2017 Nov 4. pii: S0090-8258(17)31449.
    PubMed     Text format     Abstract available


    October 2017
  46. NING MS, Ahobila V, Jhingran A, Stecklein SR, et al
    Outcomes and patterns of relapse after definitive radiation therapy for oligometastatic cervical cancer.
    Gynecol Oncol. 2017 Oct 28. pii: S0090-8258(17)31420.
    PubMed     Text format     Abstract available


  47. LEE JH, Lee SW, Kim JR, Kim YS, et al
    Tumour size, volume, and marker expression during radiation therapy can predict survival of cervical cancer patients: a multi-institutional retrospective analysis of KROG 16-01.
    Gynecol Oncol. 2017 Oct 27. pii: S0090-8258(17)31360.
    PubMed     Text format     Abstract available


  48. LAAN JJ, van Lonkhuijzen LRCW, van Os RM, Tytgat KM, et al
    Socioeconomic status as an independent risk factor for severe late bowel toxicity after primary radiotherapy for cervical cancer.
    Gynecol Oncol. 2017 Oct 23. pii: S0090-8258(17)31416.
    PubMed     Text format     Abstract available


  49. YAMAMOTO K, Nagao S, Suzuki K, Kogiku A, et al
    Pelvic fractures after definitive and postoperative radiotherapy for cervical cancer: A retrospective analysis of risk factors.
    Gynecol Oncol. 2017 Oct 18. pii: S0090-8258(17)31359.
    PubMed     Text format     Abstract available


  50. CHEN BJ, Byrne FL, Takenaka K, Modesitt SC, et al
    Transcriptome landscape of long intergenic non-coding RNAs in endometrial cancer.
    Gynecol Oncol. 2017 Oct 16. pii: S0090-8258(17)31367.
    PubMed     Text format     Abstract available


  51. DE LIMA MAP, Neto PJN, Lima LPM, Goncalves Junior J, et al
    Association between Epstein-Barr virus (EBV) and cervical carcinoma: A meta-analysis.
    Gynecol Oncol. 2017 Oct 9. pii: S0090-8258(17)31366.
    PubMed     Text format     Abstract available


    September 2017
  52. PHILP L, Covens A, Vicus D, Kupets R, et al
    Feasibility and safety of same-day discharge after laparoscopic radical hysterectomy for cervix cancer.
    Gynecol Oncol. 2017 Sep 28. pii: S0090-8258(17)31350.
    PubMed     Text format     Abstract available


  53. MAKKONEN P, Heinavaara S, Sarkeala T, Anttila A, et al
    Impact of organized and opportunistic Pap testing on the risk of cervical cancer in young women - A case-control study from Finland.
    Gynecol Oncol. 2017 Sep 21. pii: S0090-8258(17)31335.
    PubMed     Text format     Abstract available


  54. LEE SW, Lee SH, Kim J, Kim YS, et al
    Magnetic resonance imaging during definitive chemoradiotherapy can predict tumor recurrence and patient survival in locally advanced cervical cancer: A multi-institutional retrospective analysis of KROG 16-01.
    Gynecol Oncol. 2017 Sep 18. pii: S0090-8258(17)31265.
    PubMed     Text format     Abstract available


  55. RAUH LA, Pannone AF, Cantrell LA
    Hormone replacement therapy after treatment for cervical cancer: Are we adhering to standard of care?
    Gynecol Oncol. 2017 Sep 16. pii: S0090-8258(17)31333.
    PubMed     Text format     Abstract available


  56. AZAIS H, Ghesquiere L, Petitnicolas C, Borghesi Y, et al
    Pretherapeutic staging of locally advanced cervical cancer: Inframesenteric paraaortic lymphadenectomy accuracy to detect paraaortic metastases in comparison with infrarenal paraaortic lymphadenectomy.
    Gynecol Oncol. 2017 Sep 14. pii: S0090-8258(17)31334.
    PubMed     Text format     Abstract available


  57. HUO D, Anderson D, Palmer JR, Herbst AL, et al
    Incidence rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: Update after 40-year follow-up.
    Gynecol Oncol. 2017;146:566-571.
    PubMed     Text format     Abstract available


  58. LOPEZ LABROUSSE MI, Frumovitz M, Guadalupe Patrono M, Ramirez PT, et al
    Sentinel lymph node mapping in minimally invasive surgery: Role of imaging with color-segmented fluorescence (CSF).
    Gynecol Oncol. 2017;146:676-677.
    PubMed     Text format     Abstract available


    August 2017
  59. HEIJKOOP ST, Nout RA, Quint S, Mens JWM, et al
    Dynamics of patient reported quality of life and symptoms in the acute phase of online adaptive external beam radiation therapy for locally advanced cervical cancer.
    Gynecol Oncol. 2017 Aug 19. pii: S0090-8258(17)31247.
    PubMed     Text format     Abstract available


    July 2017
  60. CHAN JK, Deng W, Higgins RV, Tewari KS, et al
    A phase II evaluation of brivanib in the treatment of persistent or recurrent carcinoma of the cervix: An NRG Oncology/Gynecologic Oncology Group study.
    Gynecol Oncol. 2017 Jul 17. pii: S0090-8258(17)30889.
    PubMed     Text format     Abstract available


  61. DE AZEVEDO CRAS, Thuler LCS, de Mello MJG, de Oliveira Lima JT, et al
    Phase II trial of neoadjuvant chemotherapy followed by chemoradiation in locally advanced cervical cancer.
    Gynecol Oncol. 2017 Jul 11. pii: S0090-8258(17)31023.
    PubMed     Text format     Abstract available


  62. QIAN Y, Pollom EL, Nwachukwu C, Seiger K, et al
    Extent of lymphovascular space invasion may predict lymph node metastasis in uterine serous carcinoma.
    Gynecol Oncol. 2017 Jul 11. pii: S0090-8258(17)31137.
    PubMed     Text format     Abstract available


  63. LENNOX GK, Covens A
    Management Of Early Stage Cervical Cancer: When Is Non-Randomized Data Good Enough?
    Gynecol Oncol. 2017;146:1-2.
    PubMed     Text format    


    June 2017
  64. MOSS HA, Havrilesky LJ, Chino J
    Insurance coverage among women diagnosed with a gynecologic malignancy before and after implementation of the Affordable Care Act.
    Gynecol Oncol. 2017 Jun 19. pii: S0090-8258(17)30953.
    PubMed     Text format     Abstract available


  65. CASTLE PE, Kinney WK, Cheung LC, Gage JC, et al
    Why does cervical cancer occur in a state-of-the-art screening program?
    Gynecol Oncol. 2017 Jun 10. pii: S0090-8258(17)30898.
    PubMed     Text format     Abstract available


  66. CHUNG TKH, Cheung TH, Yim SF, Yu MY, et al
    Liquid biopsy of PIK3CA mutations in cervical cancer in Hong Kong Chinese women.
    Gynecol Oncol. 2017 Jun 3. pii: S0090-8258(17)30894.
    PubMed     Text format     Abstract available


  67. MATSUMOTO Y, Mabuchi S, Kozasa K, Kuroda H, et al
    The significance of tumor-associated neutrophil density in uterine cervical cancer treated with definitive radiotherapy.
    Gynecol Oncol. 2017;145:469-475.
    PubMed     Text format     Abstract available


    May 2017
  68. KANAO H, Aoki Y, Hisa T, Takeshima N, et al
    Total laparoscopic pelvic exenteration for a laterally recurrent cervical carcinoma with a vesicovaginal fistula that developed after concurrent chemoradiotherapy.
    Gynecol Oncol. 2017 May 30. pii: S0090-8258(17)30886.
    PubMed     Text format     Abstract available


  69. STEEN R, Dahl AA, Hess SL, Kiserud CE, et al
    A study of chronic fatigue in Norwegian cervical cancer survivors.
    Gynecol Oncol. 2017 May 25. pii: S0090-8258(17)30884.
    PubMed     Text format     Abstract available


  70. WOLF B, Ganzer R, Stolzenburg JU, Hentschel B, et al
    Extended mesometrial resection (EMMR): Surgical approach to the treatment of locally advanced cervical cancer based on the theory of ontogenetic cancer fields.
    Gynecol Oncol. 2017 May 16. pii: S0090-8258(17)30845.
    PubMed     Text format     Abstract available


  71. KAMRAN SC, Manuel MM, Cho LP, Damato AL, et al
    Comparison of outcomes for MR-guided versus CT-guided high-dose-rate interstitial brachytherapy in women with locally advanced carcinoma of the cervix.
    Gynecol Oncol. 2017;145:284-290.
    PubMed     Text format     Abstract available


  72. DATTA NR, Stutz E, Liu M, Rogers S, et al
    Concurrent chemoradiotherapy vs. radiotherapy alone in locally advanced cervix cancer: A systematic review and meta-analysis.
    Gynecol Oncol. 2017;145:374-385.
    PubMed     Text format     Abstract available


    April 2017
  73. LEE J, Lin JB, Chang CL, Jan YT, et al
    Prophylactic lower para-aortic irradiation using intensity-modulated radiotherapy mitigates the risk of para-aortic recurrence in locally advanced cervical cancer: A 10-year institutional experience.
    Gynecol Oncol. 2017 Apr 27. pii: S0090-8258(17)30797.
    PubMed     Text format     Abstract available


  74. HARPER DM, DeMars LR
    HPV vaccines - A review of the first decade.
    Gynecol Oncol. 2017 Apr 22. pii: S0090-8258(17)30774.
    PubMed     Text format     Abstract available


  75. BAIOCCHI G, de Brot L, Faloppa CC, Mantoan H, et al
    Is parametrectomy always necessary in early-stage cervical cancer?
    Gynecol Oncol. 2017 Apr 6. pii: S0090-8258(17)30769.
    PubMed     Text format     Abstract available


  76. LI H, Sheng Y, Zhang Y, Gao N, et al
    MicroRNA-138 is a potential biomarker and tumor suppressor in human cervical carcinoma by reversely correlated with TCF3 gene.
    Gynecol Oncol. 2017 Apr 3. pii: S0090-8258(17)30062.
    PubMed     Text format     Abstract available


    March 2017
  77. RADER JS, Sill MW, Beumer JH, Lankes HA, et al
    A stratified randomized double-blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study.
    Gynecol Oncol. 2017 Mar 9. pii: S0090-8258(17)30161.
    PubMed     Text format     Abstract available


  78. WANG YM, Wang CJ, Fang FM, Chen HC, et al
    Differences in the outcomes and complications between elderly and younger uterine cervical cancer patients treated by definitive radiotherapy - A propensity score-matched study.
    Gynecol Oncol. 2017 Mar 5. pii: S0090-8258(17)30155.
    PubMed     Text format     Abstract available


    February 2017
  79. RING KL, Yemelyanova AV, Soliman PT, Frumovitz MM, et al
    Potential immunotherapy targets in recurrent cervical cancer.
    Gynecol Oncol. 2017 Feb 20. pii: S0090-8258(17)30148.
    PubMed     Text format     Abstract available


  80. LAIRSON DR, Fu S, Chan W, Xu L, et al
    Mean direct medical care costs associated with cervical cancer for commercially insured patients in Texas.
    Gynecol Oncol. 2017 Feb 10. pii: S0090-8258(17)30122.
    PubMed     Text format     Abstract available


  81. SALVO G, Ramirez PT, Levenback CF, Munsell MF, et al
    Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer.
    Gynecol Oncol. 2017 Feb 7. pii: S0090-8258(17)30116.
    PubMed     Text format     Abstract available


  82. VERLOOP J, van Leeuwen FE, Helmerhorst TJ, de Kok IM, et al
    Risk of cervical intra-epithelial neoplasia and invasive cancer of the cervix in DES daughters.
    Gynecol Oncol. 2017;144:305-311.
    PubMed     Text format     Abstract available


    January 2017
  83. HO CK, Kornaga EN, Klimowicz AC, Enwere EK, et al
    Expression of DNA damage response proteins in cervical cancer patients treated with radical chemoradiotherapy.
    Gynecol Oncol. 2017 Jan 25. pii: S0090-8258(16)31689.
    PubMed     Text format     Abstract available


  84. LEE YJ, Kim DY, Lee SW, Park JY, et al
    A postoperative scoring system for distant recurrence in node-positive cervical cancer patients after radical hysterectomy and pelvic lymph node dissection with para-aortic lymph node sampling or dissection.
    Gynecol Oncol. 2017 Jan 17. pii: S0090-8258(17)30001.
    PubMed     Text format     Abstract available


  85. ALEXANDRE E, Sebastien G, Renaud M, Enrica B, et al
    Outcome of early stage cervical cancer patients treated according to a radiosurgical approach: Clinical results and prognostic factors.
    Gynecol Oncol. 2017 Jan 14. pii: S0090-8258(16)31690.
    PubMed     Text format     Abstract available


  86. SWAILES AL, Gockley A, Phaeton R, Kesterson JP, et al
    The Wertheim hysterectomy: Development, modifications, and impact in the present day.
    Gynecol Oncol. 2017 Jan 13. pii: S0090-8258(17)30049.
    PubMed     Text format     Abstract available


  87. BEDELL S, Manders D, Kehoe S, Lea J, et al
    The opinions and practices of providers toward the sexual issues of cervical cancer patients undergoing treatment.
    Gynecol Oncol. 2017 Jan 9. pii: S0090-8258(16)31686.
    PubMed     Text format     Abstract available


  88. ANGIOLO G, Silvestro C, Giovanni A
    Neuroendrocrine tumors of the uterine cervix: A therapeutic challenge for gynecologic oncologists.
    Gynecol Oncol. 2017 Jan 2. pii: S0090-8258(16)31621.
    PubMed     Text format     Abstract available


  89. FRUMOVITZ M
    Sentinel Lymph Node Biopsy for Cervical Cancer Patients - What's It Gonna Take?
    Gynecol Oncol. 2017;144:3-4.
    PubMed     Text format    


  90. WRIGHT TC JR, Behrens CM, Ranger-Moore J, Rehm S, et al
    Triaging HPV-positive women with p16/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial.
    Gynecol Oncol. 2017;144:51-56.
    PubMed     Text format     Abstract available


  91. FRUMOVITZ M, Munsell MF, Burzawa JK, Byers LA, et al
    Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in recurrent small cell neuroendocrine carcinoma of the cervix.
    Gynecol Oncol. 2017;144:46-50.
    PubMed     Text format     Abstract available


    November 2016
  92. SAPIENZA LG, Gomes MJ, Calsavara VF, Leitao MM Jr, et al
    Does para-aortic irradiation reduce the risk of distant metastasis in advanced cervical cancer? A systematic review and meta-analysis of randomized clinical trials.
    Gynecol Oncol. 2016 Nov 28. pii: S0090-8258(16)31613.
    PubMed     Text format     Abstract available


  93. KUJI S, Watanabe R, Sato Y, Iwata T, et al
    A new marker, insulinoma-associated protein 1 (INSM1), for high-grade neuroendocrine carcinoma of the uterine cervix: Analysis of 37 cases.
    Gynecol Oncol. 2016 Nov 28. pii: S0090-8258(16)31576.
    PubMed     Text format     Abstract available


  94. ROSS GREEN W, Hathout L, Khan AJ, Elshaikh MA, et al
    Revisiting Milan cervical cancer study: Do the original findings hold in the era of chemotherapy?
    Gynecol Oncol. 2016 Nov 26. pii: S0090-8258(16)31603.
    PubMed     Text format     Abstract available


  95. BEACHLER DC, Tota JE, Silver MI, Kreimer AR, et al
    Trends in cervical cancer incidence in younger US women from 2000 to 2013.
    Gynecol Oncol. 2016 Nov 25. pii: S0090-8258(16)31600.
    PubMed     Text format     Abstract available


  96. SULLIVAN SA, Clark LH, Staley AS, Tran AQ, et al
    Association between timing of cervical excision procedure to minimally invasive hysterectomy and surgical complications.
    Gynecol Oncol. 2016 Nov 25. pii: S0090-8258(16)31606.
    PubMed     Text format     Abstract available


  97. KONG TW, Lee JD, Son JH, Paek J, et al
    Corrigendum to 'Treatment outcomes in patients with FIGO stage IB-IIA cervical cancer and a focally disrupted cervical stromal ring on magnetic resonance imaging: A propensity score matching study' [Gynecol. Oncol. 143 (2016) 77-82].
    Gynecol Oncol. 2016 Nov 24. pii: S0090-8258(16)31522.
    PubMed     Text format    


  98. SMITH B, McCann GA, Phillips G, Backes FJ, et al
    Less radical surgery for early-stage cervical cancer: Can conization specimens help identify patients at low risk for parametrial involvement?
    Gynecol Oncol. 2016 Nov 21. pii: S0090-8258(16)31598.
    PubMed     Text format     Abstract available


  99. SHIM SH, Kim DY, Lee SJ, Kim SN, et al
    Prediction model for para-aortic lymph node metastasis in patients with locally advanced cervical cancer.
    Gynecol Oncol. 2016 Nov 14. pii: S0090-8258(16)31568.
    PubMed     Text format     Abstract available


  100. DEL CARMEN MG, Rice LW
    International Gynecologic Cancer Society (IGCS) 2016: Meeting report.
    Gynecol Oncol. 2016 Nov 12. pii: S0090-8258(16)31572.
    PubMed     Text format    


    October 2016
  101. KIM JY, Byun SJ, Kim YS, Nam JH, et al
    Disease courses in patients with residual tumor following concurrent chemoradiotherapy for locally advanced cervical cancer.
    Gynecol Oncol. 2016 Oct 24. pii: S0090-8258(16)31509.
    PubMed     Text format     Abstract available


  102. HAQUE W, Verma V, Fakhreddine M, Hatch S, et al
    Addition of chemotherapy to definitive radiotherapy for IB1 and IIA1 cervical cancer: Analysis of the National Cancer Data Base.
    Gynecol Oncol. 2016 Oct 23. pii: S0090-8258(16)31510.
    PubMed     Text format     Abstract available


  103. MAHMOUD O, Hathout L, Shaaban SG, Elshaikh MA, et al
    Can chemotherapy boost the survival benefit of adjuvant radiotherapy in early stage cervical cancer with intermediate risk factors? A population based study.
    Gynecol Oncol. 2016 Oct 18. pii: S0090-8258(16)31499.
    PubMed     Text format     Abstract available


  104. FLEMING ND, Ramirez PT, Soliman PT, Schmeler KM, et al
    Quality of life after radical trachelectomy for early-stage cervical cancer: A 5-year prospective evaluation.
    Gynecol Oncol. 2016 Oct 11. pii: S0090-8258(16)31484.
    PubMed     Text format     Abstract available


  105. LENNOX GK, Covens A
    Can sentinel lymph node biopsy replace pelvic lymphadenectomy for early cervical cancer?
    Gynecol Oncol. 2016 Oct 11. pii: S0090-8258(16)31358.
    PubMed     Text format     Abstract available


  106. BARRINGTON DA, Dilley SE, Landers EE, Thomas ED, et al
    Distance from a Comprehensive Cancer Center: A proxy for poor cervical cancer outcomes?
    Gynecol Oncol. 2016 Oct 6. pii: S0090-8258(16)31475.
    PubMed     Text format     Abstract available


  107. CHO LP, Manuel M, Catalano P, Lee L, et al
    Outcomes with volume-based dose specification in CT-planned high-dose-rate brachytherapy for stage I-II cervical carcinoma: A 10-year institutional experience.
    Gynecol Oncol. 2016 Oct 6. pii: S0090-8258(16)31423.
    PubMed     Text format     Abstract available


    September 2016
  108. MISHKIN G, Minasian LM, Kohn EC, Noone AM, et al
    The generalizability of NCI-sponsored clinical trials accrual among women with gynecologic malignancies.
    Gynecol Oncol. 2016 Sep 30. pii: S0090-8258(16)31432.
    PubMed     Text format     Abstract available


  109. WHITE ID, Sangha A, Lucas G, Wiseman T, et al
    Assessment of sexual difficulties associated with multi-modal treatment for cervical or endometrial cancer: A systematic review of measurement instruments.
    Gynecol Oncol. 2016 Sep 23. pii: S0090-8258(16)31359.
    PubMed     Text format     Abstract available


  110. WILBUR MB, Mannschreck DB, Angarita AM, Matsuno RK, et al
    Unplanned 30-day hospital readmission as a quality measure in gynecologic oncology.
    Gynecol Oncol. 2016 Sep 21. pii: S0090-8258(16)31426.
    PubMed     Text format     Abstract available


  111. STECKLEIN SR, Jhingran A, Burzawa J, Ramalingam P, et al
    Patterns of recurrence and survival in neuroendocrine cervical cancer.
    Gynecol Oncol. 2016 Sep 16. pii: S0090-8258(16)31409.
    PubMed     Text format     Abstract available


  112. ROBIN TP, Amini A, Schefter TE, Behbakht K, et al
    Disparities in standard of care treatment and associated survival decrement in patients with locally advanced cervical cancer.
    Gynecol Oncol. 2016 Sep 15. pii: S0090-8258(16)31412.
    PubMed     Text format     Abstract available


  113. SAWAYA GF
    Cervical cancer screening in women over 65. CON: Reasons for uncertainty.
    Gynecol Oncol. 2016;142:383-4.
    PubMed     Text format    


    August 2016
  114. CAMPOS-PARRA AD, Padua-Bracho A, Pedroza-Torres A, Figueroa-Gonzalez G, et al
    Comprehensive transcriptome analysis identifies pathways with therapeutic potential in locally advanced cervical cancer.
    Gynecol Oncol. 2016 Aug 28. pii: S0090-8258(16)31353.
    PubMed     Text format     Abstract available


  115. MOORE KN, Java JJ, Slaughter KN, Rose PG, et al
    Is age a prognostic biomarker for survival among women with locally advanced cervical cancer treated with chemoradiation? An NRG Oncology/Gynecologic Oncology Group ancillary data analysis.
    Gynecol Oncol. 2016 Aug 16. pii: S0090-8258(16)31343.
    PubMed     Text format     Abstract available


  116. BEAVIS AL, Salazar-Marioni S, Sinno AK, Stone RL, et al
    Sentinel lymph node detection rates using indocyanine green in women with early-stage cervical cancer.
    Gynecol Oncol. 2016 Aug 12. pii: S0090-8258(16)31259.
    PubMed     Text format     Abstract available


  117. RENDON GJ, Echeverri L, Echeverri F, Sanz-Lomana CM, et al
    Outpatient laparoscopic nerve-sparing radical hysterectomy: A feasibility study and analysis of perioperative outcomes.
    Gynecol Oncol. 2016 Aug 9. pii: S0090-8258(16)31256.
    PubMed     Text format     Abstract available


    July 2016
  118. FRUMOVITZ M, Burzawa JK, Byers LA, Lyons YA, et al
    Corrigendum to "Sequencing of mutational hotspots in cancer-related genes in small cell neuroendocrine cervical cancer" [Gynecol. Oncol. 141 (2016) 588-591].
    Gynecol Oncol. 2016 Jul 28. pii: S0090-8258(16)30979.
    PubMed     Text format    


  119. KONG TW, Lee JD, Son JH, Paek J, et al
    Treatment outcomes in patients with FIGO stage IB-IIA cervical cancer and a focally disrupted cervical stromal ring on magnetic resonance imaging: A propensity score matching study.
    Gynecol Oncol. 2016 Jul 14. pii: S0090-8258(16)30969.
    PubMed     Text format     Abstract available


  120. PEDROZA-TORRES A, Fernandez-Retana J, Peralta-Zaragoza O, Jacobo-Herrera N, et al
    A microRNA expression signature for clinical response in locally advanced cervical cancer.
    Gynecol Oncol. 2016 Jul 13. pii: S0090-8258(16)30962.
    PubMed     Text format     Abstract available


  121. CIBULA D, Zikan M, Slama J, Fischerova D, et al
    Risk of micrometastases in non-sentinel pelvic lymph nodes in cervical cancer.
    Gynecol Oncol. 2016 Jul 12. pii: S0090-8258(16)30968.
    PubMed     Text format     Abstract available


  122. SLAMA J, Cerny A, Dusek L, Fischerova D, et al
    Results of less radical fertility-sparing procedures with omitted parametrectomy for cervical cancer: 5years of experience.
    Gynecol Oncol. 2016 Jul 7. pii: S0090-8258(16)30877.
    PubMed     Text format     Abstract available


  123. ROSENBLATT KA, Osterbur EF, Douglas JA
    Case-control study of cervical cancer and gynecologic screening: A SEER-Medicare analysis.
    Gynecol Oncol. 2016 Jul 4. pii: S0090-8258(16)30827.
    PubMed     Text format     Abstract available


    June 2016
  124. MATSUO K, Moeini A, Machida H, Fullerton ME, et al
    Significance of venous thromboembolism in women with cervical cancer.
    Gynecol Oncol. 2016 Jun 24. pii: S0090-8258(16)30817.
    PubMed     Text format     Abstract available


    May 2016
  125. BROWN AJ, Shah JS, Fleming ND, Nick AM, et al
    Role of cervical cytology in surveillance after radical trachelectomy for cervical cancer.
    Gynecol Oncol. 2016 May 28. pii: S0090-8258(16)30762.
    PubMed     Text format     Abstract available


  126. UPPAL S, Del Carmen MG, Rice LW, Reynolds RK, et al
    Variation in care in concurrent chemotherapy administration during radiation for locally advanced cervical cancer.
    Gynecol Oncol. 2016 May 28. pii: S0090-8258(16)30755.
    PubMed     Text format     Abstract available


  127. LIAO JB
    Immunotherapy for Gynecologic Cancers: State of the Science.
    Gynecol Oncol. 2016 May 27. pii: S0090-8258(16)30758.
    PubMed     Text format    


  128. KONG TW, Kim J, Son JH, Kang SW, et al
    Preoperative nomogram for prediction of microscopic parametrial infiltration in patients with FIGO stage IB cervical cancer treated with radical hysterectomy.
    Gynecol Oncol. 2016 May 11. pii: S0090-8258(16)30683.
    PubMed     Text format     Abstract available


  129. ATRI M, Zhang Z, Dehdashti F, Lee SI, et al
    Utility of PET-CT to Evaluate Retroperitoneal Lymph Node Metastasis in Advanced Cervical Cancer: Results of ACRIN6671/GOG0233 Trial.
    Gynecol Oncol. 2016 May 10. pii: S0090-8258(16)30681.
    PubMed     Text format     Abstract available


    April 2016
  130. CHATZISTAMATIOU K, Moysiadis T, Moschaki V, Panteleris N, et al
    Comparison of cytology, HPV DNA testing and HPV 16/18 genotyping alone or combined targeting to the more balanced methodology for cervical cancer screening.
    Gynecol Oncol. 2016 Apr 25. pii: S0090-8258(16)30159.
    PubMed     Text format     Abstract available


  131. SALVATICI M, Achilarre MT, Sandri MT, Boveri S, et al
    Squamous cell carcinoma antigen (SCC-Ag) during follow-up of cervical cancer patients: role in the early diagnosis of recurrence.
    Gynecol Oncol. 2016 Apr 23. pii: S0090-8258(16)30162.
    PubMed     Text format     Abstract available


  132. FRUMOVITZ M, Burzawa JK, Byers LA, Lyons YA, et al
    Sequencing of mutational hotspots in cancer-related genes in small cell neuroendocrine cervical cancer.
    Gynecol Oncol. 2016 Apr 11. pii: S0090-8258(16)30102.
    PubMed     Text format     Abstract available


  133. CLARK LH, Jackson AL, Soo AE, Orrey DC, et al
    Extremes in body mass index affect overall survival in women with cervical cancer.
    Gynecol Oncol. 2016 Apr 4. pii: S0090-8258(16)30091.
    PubMed     Text format     Abstract available


  134. ROMA AA, Mistretta TA, Diaz De Vivar A, Park KJ, et al
    New pattern-based personalized risk stratification system for endocervical adenocarcinoma with important clinical implications and surgical outcome.
    Gynecol Oncol. 2016;141:36-42.
    PubMed     Text format     Abstract available


  135. KYRGIOU M, Pouliakis A, Panayiotides JG, Margari N, et al
    Personalised management of women with cervical abnormalities using a clinical decision support scoring system.
    Gynecol Oncol. 2016;141:29-35.
    PubMed     Text format     Abstract available


    March 2016
  136. MANLEY KM, Wills AK, Morris GC, Hogg JL, et al
    The impact of HPV cervical screening on negative large loop excision of the transformation zone (LLETZ): A comparative cohort study.
    Gynecol Oncol. 2016 Mar 28. pii: S0090-8258(16)30088.
    PubMed     Text format     Abstract available


  137. HOLST S, Wohlfahrt J, Kjaer SK, Kamper-Jorgensen M, et al
    Cervical cancer screening in Greenland, 1997-2011: Screening coverage and trends in the incidence of high-grade cervical lesions.
    Gynecol Oncol. 2016 Mar 23. pii: S0090-8258(16)30085.
    PubMed     Text format     Abstract available


  138. CHURILLA T, Egleston B, Dong Y, Shaikh T, et al
    Disparities in the Management and Outcome of Cervical Cancer in the United States According to Health Insurance Status.
    Gynecol Oncol. 2016 Mar 21. pii: S0090-8258(16)30081.
    PubMed     Text format     Abstract available


    February 2016
  139. DE STROOPER LM, Verhoef VM, Berkhof J, Hesselink AT, et al
    Validation of the FAM19A4/mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive women.
    Gynecol Oncol. 2016 Feb 24. pii: S0090-8258(16)30036.
    PubMed     Text format     Abstract available


  140. MABUCHI S, Isohashi F, Yokoi T, Takemura M, et al
    A phase II study of postoperative concurrent carboplatin and paclitaxel combined with intensity-modulated pelvic radiotherapy followed by consolidation chemotherapy in surgically treated cervical cancer patients with positive pelvic lymph nodes.
    Gynecol Oncol. 2016 Feb 13. pii: S0090-8258(16)30035.
    PubMed     Text format     Abstract available


  141. FAN D, Wang Y, Qi P, Chen Y, et al
    MicroRNA-183 functions as the tumor suppressor via inhibiting cellular invasion and metastasis by targeting MMP-9 in cervical cancer.
    Gynecol Oncol. 2016 Feb 9. pii: S0090-8258(16)30032.
    PubMed     Text format     Abstract available


  142. WU L, Yao C, Xiong Z, Zhang R, et al
    The effects of a picosecond pulsed electric field on angiogenesis in the cervical cancer xenograft models.
    Gynecol Oncol. 2016 Feb 3. pii: S0090-8258(16)30027.
    PubMed     Text format     Abstract available


  143. JOHANSEN G, Lonnerfors C, Falconer H, Persson J, et al
    Reproductive and oncologic outcome following robot-assisted laparoscopic radical trachelectomy for early stage cervical cancer.
    Gynecol Oncol. 2016 Feb 1. pii: S0090-8258(16)30026.
    PubMed     Text format     Abstract available


  144. ALVAREZ RD, Huh WK, Bae S, Lamb LS Jr, et al
    A pilot study of pNGVL4a-CRT/E7(detox) for the treatment of patients with HPV16+ cervical intraepithelial neoplasia 2/3 (CIN2/3).
    Gynecol Oncol. 2016;140:245-52.
    PubMed     Text format     Abstract available


    January 2016
  145. WESTIN SN, Randall L
    The European Society of Gynecologic Oncology (ESGO) 19th biannual meeting: Overview and summary of selected topics.
    Gynecol Oncol. 2016 Jan 22. pii: S0090-8258(16)00040.
    PubMed     Text format    


    December 2015
  146. UMAYAHARA K, Takekuma M, Hirashima Y, Noda SE, et al
    Phase II study of concurrent chemoradiotherapy with weekly cisplatin and paclitaxel in patients with locally advanced uterine cervical cancer: The JACCRO GY-01 trial.
    Gynecol Oncol. 2015 Dec 14. pii: S0090-8258(15)30212.
    PubMed     Text format     Abstract available


    November 2015
  147. WU ES, Oduyebo T, Cobb LP, Cholakian D, et al
    Lymphopenia and its association with survival in patients with locally advanced cervical cancer.
    Gynecol Oncol. 2015 Nov 10. pii: S0090-8258(15)30185.
    PubMed     Text format     Abstract available


  148. LEE JY, Kwon JS, Cohn DE, Kim Y, et al
    Treatment strategies for stage IB cervical cancer: A cost-effectiveness analysis from Korean, Canadian and US perspectives.
    Gynecol Oncol. 2015 Nov 5. pii: S0090-8258(15)30179.
    PubMed     Text format     Abstract available


  149. DE WITTE CJ, van de Sande AJ, van Beekhuizen HJ, Koeneman MM, et al
    Imiquimod in cervical, vaginal and vulvar intraepithelial neoplasia: a review.
    Gynecol Oncol. 2015;139:377-84.
    PubMed     Text format     Abstract available


    October 2015
  150. RAMONDETTA LM, Meyer LA, Schmeler KM, Daheri ME, et al
    Avoidable tragedies: Disparities in healthcare access among medically underserved women diagnosed with cervical cancer.
    Gynecol Oncol. 2015 Oct 21. pii: S0090-8258(15)30165.
    PubMed     Text format     Abstract available


  151. KIM KH, Kim S, Kim GE, Koom WS, et al
    De-escalation of the cumulative central radiation dose according to the tumor response can reduce rectal toxicity without compromising the treatment outcome in patients with uterine cervical cancer.
    Gynecol Oncol. 2015 Oct 9. pii: S0090-8258(15)30154.
    PubMed     Text format     Abstract available


  152. ZHANG P, Yang B, Yao YY, Zhong LX, et al
    PIAS3, SHP2 and SOCS3 Expression patterns in Cervical Cancers: Relevance with activation and resveratrol-caused inactivation of STAT3 signaling.
    Gynecol Oncol. 2015 Oct 2. pii: S0090-8258(15)30148.
    PubMed     Text format     Abstract available


  153. HARDIKAR S, Johnson LG, Malkki M, Petersdorf EW, et al
    A population-based case-control study of genetic variation in cytokine genes associated with risk of cervical and vulvar cancers.
    Gynecol Oncol. 2015;139:90-6.
    PubMed     Text format     Abstract available


    September 2015
  154. KIM YJ, Munsell MF, Park JC, Meyer LA, et al
    Retrospective review of symptoms and palliative care interventions in women with advanced cervical cancer.
    Gynecol Oncol. 2015 Sep 29. pii: S0090-8258(15)30140.
    PubMed     Text format     Abstract available


  155. ANGIOLI R, Plotti F, Aloisi A, Scaletta G, et al
    A randomized controlled trial comparing four versus six courses of adjuvant platinum-based chemotherapy in locally advanced cervical cancer patients previously treated with neo-adjuvant chemotherapy plus radical surgery.
    Gynecol Oncol. 2015 Sep 28. pii: S0090-8258(15)30143.
    PubMed     Text format    


  156. TAX C, Rovers MM, de Graaf C, Zusterzeel PL, et al
    The sentinel node procedure in early stage cervical cancer, taking the next step; a diagnostic review.
    Gynecol Oncol. 2015 Sep 25. pii: S0090-8258(15)30137.
    PubMed     Text format     Abstract available


  157. ANDERSEN CL, Eskelund CW, Siersma VD, Felding P, et al
    is thrombocytosis a valid indicator of advanced stage and high mortality of gynecological cancer?
    Gynecol Oncol. 2015 Sep 22. pii: S0090-8258(15)30133.
    PubMed     Text format    


  158. O'HANLAN KA, Sten MS, O'Holleran MS, Ford NN, et al
    Infrarenal lymphadenectomy for gynecological malignancies: Two laparoscopic approaches.
    Gynecol Oncol. 2015 Sep 22. pii: S0090-8258(15)30135.
    PubMed     Text format     Abstract available


  159. CASTELNAU-MARCHAND P, Chargari C, Maroun P, Dumas I, et al
    Clinical outcomes of definitive chemoradiation followed by intracavitary pulsed-dose rate image-guided adaptive brachytherapy in locally advanced cervical cancer.
    Gynecol Oncol. 2015 Sep 10. pii: S0090-8258(15)30125.
    PubMed     Text format     Abstract available


  160. YAMAZAKI H, Todo Y, Takeshita S, Ohba Y, et al
    Relationship between removal of circumflex iliac nodes distal to the external iliac nodes and postoperative lower-extremity lymphedema in uterine cervical cancer.
    Gynecol Oncol. 2015 Sep 10. pii: S0090-8258(15)30124.
    PubMed     Text format     Abstract available


  161. IN CHOI J, Chang HK, Lee DW, Lee KH, et al
    Does diabetes mellitus have an impact on the prognosis for patients with cervical cancer?
    Gynecol Oncol. 2015 Sep 8. pii: S0090-8258(15)30121.
    PubMed     Text format     Abstract available


    August 2015
  162. SINNO AK, Tanner EJ 3rd
    Robotic Laparoendoscopic Single Site Radical Hysterectomy with Sentinel Lymph Node Mapping and Pelvic Lymphadenectomy for Cervical Cancer.
    Gynecol Oncol. 2015 Aug 22. pii: S0090-8258(15)30104.
    PubMed     Text format     Abstract available


  163. AGGARWAL R, Misra S, Guleria C, Suri V, et al
    Characterization of Toll-like receptor transcriptome in squamous cell carcinoma of cervix: A case-control study.
    Gynecol Oncol. 2015;138:358-62.
    PubMed     Text format     Abstract available


    July 2015
  164. CHAN JL, Letourneau J, Salem W, Cil AP, et al
    Sexual satisfaction and quality of life in survivors of localized cervical and ovarian cancers following fertility-sparing surgery.
    Gynecol Oncol. 2015 Jul 29. pii: S0090-8258(15)30090.
    PubMed     Text format     Abstract available


  165. HAN X, Ping B, Morita M, Ebi R, et al
    A novel highly sensitive and specific flow cytometry system for cervical cancer screening.
    Gynecol Oncol. 2015 Jul 23. pii: S0090-8258(15)30087.
    PubMed     Text format     Abstract available


  166. WRIGHT JD, Huang Y, Ananth CV, Tergas AI, et al
    Influence of Treatment Center and Hospital Volume on Survival for Locally Advanced Cervical Cancer.
    Gynecol Oncol. 2015 Jul 12. pii: S0090-8258(15)30076.
    PubMed     Text format     Abstract available


  167. CHIANTERA V, Vizzielli G, Lucidi A, Gallotta V, et al
    Laparoscopic radical hysterectomy in cervical cancer as "total mesometrial resection (L-TMMR)": A multicentric experience.
    Gynecol Oncol. 2015 Jul 9. pii: S0090-8258(15)30071.
    PubMed     Text format     Abstract available


  168. HOFLER D, Bohmer G, von Wasielewski R, Neumann H, et al
    HPV16 RNA patterns defined by novel high-throughput RT-qPCR as triage marker in HPV-based cervical cancer precursor screening.
    Gynecol Oncol. 2015 Jul 3. pii: S0090-8258(15)30060.
    PubMed     Text format     Abstract available


  169. SCHIFFMAN M, Vaughan L, Raine-Bennett TR, Castle PE, et al
    A Study of HPV Typing for the Management of HPV-Positive ASC-US Cervical Cytologic Results.
    Gynecol Oncol. 2015 Jul 3. pii: S0090-8258(15)30061.
    PubMed     Text format     Abstract available


  170. FRIMER M, Sun C, McAndrew T, Smith B, et al
    HPV16 CpG methyl-haplotypes are associated with cervix precancer and cancer in the Guanacaste natural history study.
    Gynecol Oncol. 2015;138:94-100.
    PubMed     Text format     Abstract available


    June 2015
  171. POL FJ, Zusterzeel PL, van Ham MA, Kuijpers DA, et al
    Satellite lymphovascular space invasion: an independent risk factor in early stage cervical cancer.
    Gynecol Oncol. 2015 Jun 27. pii: S0090-8258(15)30056.
    PubMed     Text format     Abstract available


  172. YANG Z, Chen D, Zhang J, Yao D, et al
    The efficacy and safety of neoadjuvant chemotherapy in the treatment of locally advanced cervical cancer: A randomized multicenter study.
    Gynecol Oncol. 2015 Jun 23. pii: S0090-8258(15)30048.
    PubMed     Text format     Abstract available


  173. VIEIRA MA, Rendon GJ, Munsell M, Echeverri L, et al
    Radical trachelectomy in early-stage cervical cancer: A comparison of laparotomy and minimally invasive surgery.
    Gynecol Oncol. 2015 Jun 18. pii: S0090-8258(15)30044.
    PubMed     Text format     Abstract available


  174. YANG Y, Xie YJ, Xu Q, Chen JX, et al
    Down-regulation of miR-1246 in Cervical Cancer Tissues and Its Clinical Significance.
    Gynecol Oncol. 2015 Jun 11. pii: S0090-8258(15)30036.
    PubMed     Text format     Abstract available


  175. SHAZLY SA, Hassan Murad M, Dowdy SC, Gostout BS, et al
    Robotic radical hysterectomy in early stage cervical cancer: A systematic review and meta-analysis.
    Gynecol Oncol. 2015 Jun 6. pii: S0090-8258(15)30030.
    PubMed     Text format     Abstract available


  176. SALIHI R, Leunen K, Van Limbergen E, Moerman P, et al
    Neoadjuvant chemotherapy followed by large cone resection as fertility-sparing therapy in stage IB cervical cancer.
    Gynecol Oncol. 2015 Jun 4. pii: S0090-8258(15)30023.
    PubMed     Text format     Abstract available


    May 2015
  177. ZAAL A, de Wilde MA, Duk MJ, Graziosi GC, et al
    The diagnostic process of cervical cancer; areas of good practice and windows of opportunity.
    Gynecol Oncol. 2015 May 30. pii: S0090-8258(15)30019.
    PubMed     Text format     Abstract available


  178. KANGMENNAANG J, Thogarapalli N, Mkandawire P, Luginaah I, et al
    Investigating the disparities in cervical cancer screening among Namibian women.
    Gynecol Oncol. 2015 May 30. pii: S0090-8258(15)30018.
    PubMed     Text format     Abstract available


  179. HAUERBERG L, Hogdall C, Loft A, Ottosen C, et al
    Vaginal Radical Trachelectomy for early stage cervical cancer. Results of the Danish National Single Center Strategy.
    Gynecol Oncol. 2015 May 27. pii: S0090-8258(15)30001.
    PubMed     Text format     Abstract available


  180. BOONE JD, Dobbin ZC, Michael Straughn J, Buchsbaum DJ, et al
    Ovarian and cervical cancer patient derived xenografts: the past, present, and future.
    Gynecol Oncol. 2015 May 27. pii: S0090-8258(15)30004.
    PubMed     Text format     Abstract available


  181. WANG LD, Lam WW, Fielding R
    Cervical cancer prevention practices through screening and vaccination: A cross-sectional study among Hong Kong Chinese women.
    Gynecol Oncol. 2015 May 27. pii: S0090-8258(15)30003.
    PubMed     Text format     Abstract available


  182. PEEL AB, Barlow CE, Leonard D, DeFina LF, et al
    Cardiorespiratory Fitness in Survivors of Cervical, Endometrial, and Ovarian Cancer: The Cooper Center Longitudinal Study.
    Gynecol Oncol. 2015 May 27. pii: S0090-8258(15)30009.
    PubMed     Text format     Abstract available


  183. DAS S, Subhashini J, Rami Reddy JK, KantiPal S, et al
    Low dose fractionated radiation and chemotherapy prior to definitive chemoradiation in locally advanced carcinoma of the uterine cervix: Results of a prospective phase II clinical trial.
    Gynecol Oncol. 2015 May 23. pii: S0090-8258(15)00935.
    PubMed     Text format     Abstract available


  184. VANDEPERRE A, Van Limbergen E, Leunen K, Moerman P, et al
    Para-aortic lymphnode metastases in locally advanced cervical cancer: Comparison between surgical staging and imaging.
    Gynecol Oncol. 2015 May 22. pii: S0090-8258(15)00936.
    PubMed     Text format     Abstract available


  185. MUNRO A, Leung Y, Spilsbury K, Stewart CJ, et al
    Comparison of cold knife cone biopsy and loop electrosurgical excision procedure in the management of cervical adenocarcinoma in situ: What is the gold standard?
    Gynecol Oncol. 2015;137:258-63.
    PubMed     Text format     Abstract available


    April 2015
  186. BROOKS SE, Carter RL, Plaxe SC, Basen-Engquist KM, et al
    Patient and Physician Factors Associated with Participation in Cervical and Uterine Cancer Trials: An NRG/GOG247 Study.
    Gynecol Oncol. 2015 Apr 30. pii: S0090-8258(15)00862.
    PubMed     Text format     Abstract available


  187. MONSONEGO J, Cox JT, Behrens C, Sandri M, et al
    Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: data from the ATHENA trial.
    Gynecol Oncol. 2015;137:47-54.
    PubMed     Text format     Abstract available


    March 2015
  188. CHEN TC, Huang HJ, Wang TY, Yang LY, et al
    Primary Surgery versus Primary Radiation therapy for FIGO Stage I-II Small Cell Carcinoma of the Uterine Cervix: A Retrospective Taiwanese Gynecologic Oncology Group Study.
    Gynecol Oncol. 2015 Mar 19. pii: S0090-8258(15)00732.
    PubMed     Text format     Abstract available


    February 2015
  189. VALE DB, Braganca JF, Xavier-Junior JC, Dufloth RM, et al
    Usefulness of vaginal cytology tests in women with previous hysterectomy for benign diseases: assessment of 53,891 tests.
    Gynecol Oncol. 2015 Feb 19. pii: S0090-8258(15)00651.
    PubMed     Text format     Abstract available


  190. VERHOEF VM, van Kemenade FJ, Rozendaal L, Heideman DA, et al
    Follow-up of high-risk HPV positive women by combined cytology and bi-marker CADM1/MAL methylation analysis on cervical scrapes.
    Gynecol Oncol. 2015 Feb 7. pii: S0090-8258(15)00602.
    PubMed     Text format     Abstract available


    January 2015
  191. ANDY CHEN L, Kim J, Boucher K, Terakedis B, et al
    Toxicity and Cost-Effectiveness Analysis of Intensity Modulated Radiation Therapy Versus 3-Dimensional Conformal Radiation Therapy for Postoperative Treatment of Gynecologic Cancers.
    Gynecol Oncol. 2015 Jan 3. pii: S0090-8258(14)01637.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: